- Prior authorization is standard for Wegovy — it is not a denial, just a documentation step
- Thorough clinical documentation significantly increases approval likelihood
- If denied, there are multiple appeal pathways including peer-to-peer review
- PEAK handles the entire PA process so you do not have to deal with it yourself
Important GLP-1 safety warning: Wegovy carries a boxed warning for thyroid C-cell tumors. Avoid use in patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
If your provider has recommended Wegovy, there is a good chance your insurance company will require prior authorization before covering it. This is not unusual and it is not a denial. It is a standard step in the process for GLP-1 medications, and it exists so your insurer can confirm that the medication is medically necessary for your situation.
The prior authorization process can feel opaque and frustrating, but it is navigable — especially when your provider knows what to submit, how to document your case, and how to follow up. This guide walks through exactly what happens, what insurers look for, and what you can do to improve your chances of approval.
What is prior authorization?
Prior authorization (PA) is a requirement set by your insurance company that your provider must get approval before prescribing certain medications. The insurer reviews clinical documentation submitted by your provider to confirm that the medication meets their criteria for medical necessity.
For Wegovy and other GLP-1 medications, prior authorization is nearly universal. This is because these medications are high-cost and insurers want to verify that they are being prescribed to patients who meet specific clinical criteria. A prior authorization is not a judgment on whether you need the medication — it is an administrative checkpoint.
What it is: An insurance requirement before covering a medication.
Who submits it: Your provider, not you.
What it involves: Clinical documentation proving medical necessity.
How long it takes: Typically 3–14 business days for initial review.
What insurers typically require
While every insurer has slightly different criteria, the requirements for Wegovy prior authorization follow a consistent pattern. Understanding what they are looking for helps explain why thorough documentation matters so much.
- Documented BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease).
- Medical history showing weight-related conditions and their impact on your health.
- Evidence of prior weight management attempts. Some insurers require documentation that you have tried diet, exercise, or other interventions before approving a GLP-1 medication. This is sometimes called a “step therapy” requirement.
- Recent lab work, which may include metabolic panels, lipid profiles, HbA1c, or other relevant tests that support the clinical picture.
The specific requirements vary by insurer and by plan. Some plans are more straightforward than others. This is one of the reasons it matters to work with a provider who submits prior authorizations regularly and knows what each insurer expects.
Step-by-step process
The prior authorization process follows a predictable sequence. Knowing what happens at each stage removes much of the uncertainty.
Step 1: Clinical evaluation
Your provider conducts a clinical evaluation that documents your medical necessity for Wegovy. This includes recording your BMI, relevant medical history, comorbidities, previous weight management efforts, and current lab values. The quality of this initial evaluation directly affects the strength of the PA submission.
Step 2: PA submission
Your provider submits the prior authorization request to your insurance company, along with all supporting clinical documentation. This typically includes clinical notes, lab results, a letter of medical necessity, and any insurer-specific forms that must be completed.
Step 3: Insurer review
The insurer’s utilization management team reviews the submission. This review typically takes 1–2 weeks, though some insurers are faster and others are slower. During this period, the insurer may request additional information from your provider.
Step 4: Decision
The insurer issues one of three decisions: approval, denial, or a request for additional information. An approval means you can begin treatment. A denial comes with a stated reason and opens appeal pathways. A request for additional information means the insurer needs more documentation before making a decision.
The difference between a PA that gets approved and one that gets denied often comes down to how thoroughly the initial submission is documented.
How to strengthen your PA
Not all prior authorization submissions are created equal. A well-documented submission is significantly more likely to be approved than one that is incomplete or vague. Here is what makes the difference:
- Thorough documentation of BMI and weight history. Include not just your current BMI, but a documented weight trajectory over time. Insurers respond better to a pattern than a single data point.
- Include all comorbidities. If you have hypertension, type 2 diabetes, sleep apnea, high cholesterol, or cardiovascular disease, each of these should be clearly documented with supporting evidence. More comorbidities strengthen the medical necessity argument.
- Detailed weight management history. Document previous diet programs, exercise regimens, behavioral counseling, or other weight loss medications you have tried. Insurers want to see that Wegovy is not the first-line approach.
- Relevant lab values. Recent labs that support your clinical picture — such as HbA1c for diabetes, lipid panels for dyslipidemia, or liver function tests — add clinical weight to the submission.
- A clear letter of medical necessity. Written by your provider, this letter connects your clinical data to the specific criteria the insurer requires. It should be specific, not generic.
The strength of a prior authorization depends almost entirely on what your provider submits. You cannot call your insurer and argue your case the way your provider can through clinical documentation. This is why choosing a provider experienced with GLP-1 prior authorizations matters significantly.
Common reasons PAs are denied
Understanding why prior authorizations get denied helps you and your provider avoid common pitfalls. Each denial reason has a different response strategy.
- Incomplete documentation. The most common reason. Missing lab values, insufficient weight history, or a vague letter of medical necessity can result in denial even when the patient clearly qualifies. The fix: resubmit with complete documentation.
- Plan exclusion for weight loss medications. Some insurance plans categorically exclude coverage for weight loss medications. This is a plan-level exclusion, not a clinical denial. Your provider may be able to pursue coverage through a cardiovascular indication pathway if applicable.
- Step therapy requirements not met. Some insurers require evidence that you have tried and failed other weight management approaches before approving a GLP-1. If this documentation was not included in the initial submission, adding it to an appeal can resolve the issue.
- BMI does not meet threshold. If your documented BMI does not meet the insurer’s criteria (typically 30+ or 27+ with comorbidity), the PA will be denied. In some cases, BMI may have been measured at a different time or the documentation may not reflect your accurate weight. Your provider can address this with updated measurements.
An initial denial does not mean you cannot get Wegovy covered. Many denials are overturned on appeal, especially when the appeal includes stronger documentation or addresses the specific reason for denial. The key is understanding why it was denied and responding accordingly.
What to do if denied
If your prior authorization is denied, you have several options. The right approach depends on the reason for the denial.
Formal appeal
You and your provider can file a formal appeal with the insurer. This involves submitting additional documentation that addresses the specific reason for the denial. Most insurers have a defined appeal process with clear timelines and requirements.
Letter of medical necessity
Your provider can submit a detailed letter of medical necessity that specifically addresses the insurer’s denial rationale. This letter should connect your clinical data directly to the insurer’s coverage criteria and explain why Wegovy is medically appropriate for your situation.
Peer-to-peer review
Your provider can request a peer-to-peer review, which is a direct conversation between your provider and the insurer’s medical reviewer. This is often the most effective appeal mechanism because it allows your provider to present your case in real time and respond to specific questions or concerns.
Cardiovascular pathway
For patients with established cardiovascular disease (history of heart attack, stroke, or peripheral arterial disease), coverage may be pursued through Wegovy’s FDA-approved cardiovascular risk reduction indication rather than the weight management indication. This pathway may have different — sometimes more favorable — coverage criteria.
Timelines
One of the most common questions about prior authorization is how long it takes. The answer depends on your insurer and the complexity of your case, but here are the general timelines to expect.
Initial PA review: 3–14 business days, depending on the insurer. Most decisions come within 5–7 business days.
Request for additional information: If the insurer needs more documentation, this can add 1–2 weeks to the process depending on how quickly the additional information is submitted.
Appeal timeline: 30–60 days from the date the appeal is filed. Some insurers have faster appeal processes.
Expedited review: Available for urgent clinical situations. Expedited reviews are typically completed within 72 hours. Your provider must demonstrate why an expedited review is clinically warranted.
These timelines can feel long when you are ready to start treatment. The best way to minimize delays is to ensure the initial submission is thorough and complete, reducing the likelihood of requests for additional information or denials that require appeals.
How PEAK handles prior authorization
At PEAK, prior authorization is not an afterthought — it is a core part of our process. We submit prior authorizations for GLP-1 medications routinely, and we have built systems specifically to maximize approval rates and minimize the burden on our patients.
- We know what each insurer wants. We track insurer-specific requirements and tailor each PA submission to the criteria of the specific plan. A submission to Anthem looks different from a submission to Aetna, and we account for those differences.
- We document thoroughly from the start. Your initial clinical evaluation at PEAK is designed to capture everything needed for a strong PA submission. We do not wait until a denial to gather the right documentation — we get it right the first time.
- We track every submission. Every PA we submit is tracked through our system. We know where your authorization stands at all times, and we follow up proactively when timelines are exceeded.
- We follow up proactively. We do not submit and wait. Our team contacts insurers to check status, respond to requests for additional information promptly, and escalate when necessary.
- We handle appeals. If a PA is denied, we manage the entire appeal process — including peer-to-peer reviews, letters of medical necessity, and alternative coverage pathway submissions.
You should not have to become an expert in insurance administration to get the medication your provider prescribed. That is our job.
The prior authorization process is a reality of getting Wegovy covered by insurance. It can be handled successfully, but it requires attention to detail, familiarity with insurer requirements, and persistence when things do not go smoothly on the first attempt. At PEAK, we handle this entire process so that you can focus on your health, not your paperwork.
PEAK accepts commercial insurance and TRICARE. We do not accept Medicare or Medicaid, including Medicare Advantage and Medicaid managed care plans.
